BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 26237436)

  • 41. Interstitial Lung Diseases in Developing Countries.
    Rivera-Ortega P; Molina-Molina M
    Ann Glob Health; 2019 Jan; 85(1):. PubMed ID: 30741505
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact of accurate diagnosis of interstitial lung diseases on postoperative outcomes in lung cancer.
    Azuma Y; Sakamoto S; Homma S; Sano A; Sakai T; Koezuka S; Otsuka H; Tochigi N; Kishi K; Iyoda A
    Gen Thorac Cardiovasc Surg; 2023 Feb; 71(2):129-137. PubMed ID: 35999412
    [TBL] [Abstract][Full Text] [Related]  

  • 43. S100A9 in BALF is a candidate biomarker of idiopathic pulmonary fibrosis.
    Hara A; Sakamoto N; Ishimatsu Y; Kakugawa T; Nakashima S; Hara S; Adachi M; Fujita H; Mukae H; Kohno S
    Respir Med; 2012 Apr; 106(4):571-80. PubMed ID: 22209187
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Plasma Surfactant Protein-D, Matrix Metalloproteinase-7, and Osteopontin Index Distinguishes Idiopathic Pulmonary Fibrosis from Other Idiopathic Interstitial Pneumonias.
    White ES; Xia M; Murray S; Dyal R; Flaherty CM; Flaherty KR; Moore BB; Cheng L; Doyle TJ; Villalba J; Dellaripa PF; Rosas IO; Kurtis JD; Martinez FJ
    Am J Respir Crit Care Med; 2016 Nov; 194(10):1242-1251. PubMed ID: 27149370
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Interstitial lung diseases: an observational study in patients admitted in "Marius Nasta" Institute of Pulmonology Bucharest, Romania, in 2011.
    Strâmbu I; Belaconi I; Stoicescu I; Ioniţă D; Cojocaru F; Niţă C; Dospinoiu D; Bumbăcea R
    Pneumologia; 2013; 62(4):206-11. PubMed ID: 24734353
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Multicentre evaluation of multidisciplinary team meeting agreement on diagnosis in diffuse parenchymal lung disease: a case-cohort study.
    Walsh SLF; Wells AU; Desai SR; Poletti V; Piciucchi S; Dubini A; Nunes H; Valeyre D; Brillet PY; Kambouchner M; Morais A; Pereira JM; Moura CS; Grutters JC; van den Heuvel DA; van Es HW; van Oosterhout MF; Seldenrijk CA; Bendstrup E; Rasmussen F; Madsen LB; Gooptu B; Pomplun S; Taniguchi H; Fukuoka J; Johkoh T; Nicholson AG; Sayer C; Edmunds L; Jacob J; Kokosi MA; Myers JL; Flaherty KR; Hansell DM
    Lancet Respir Med; 2016 Jul; 4(7):557-565. PubMed ID: 27180021
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Baseline characteristics and comorbidities in the CAnadian REgistry for Pulmonary Fibrosis.
    Fisher JH; Kolb M; Algamdi M; Morisset J; Johannson KA; Shapera S; Wilcox P; To T; Sadatsafavi M; Manganas H; Khalil N; Hambly N; Halayko AJ; Gershon AS; Fell CD; Cox G; Ryerson CJ
    BMC Pulm Med; 2019 Nov; 19(1):223. PubMed ID: 31771541
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Interstitial Lung Disease in the Elderly.
    Patterson KC; Shah RJ; Porteous MK; Christie JD; D'Errico CA; Chadwick M; Triano MJ; Deshpande C; Rossman MD; Litzky LA; Kreider M; Miller WT
    Chest; 2017 Apr; 151(4):838-844. PubMed ID: 27865876
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Interstitial pneumonia with autoimmune features: from research classification to diagnosis.
    Glenn LM; Pugashetti JV; Oldham J; Corte TJ
    Curr Opin Pulm Med; 2021 Sep; 27(5):374-387. PubMed ID: 34183525
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical impact of the interstitial lung disease multidisciplinary service.
    Jo HE; Glaspole IN; Levin KC; McCormack SR; Mahar AM; Cooper WA; Cameron R; Ellis SJ; Cottee AM; Webster SE; Troy LK; Torzillo PJ; Corte P; Symons KM; Taylor N; Corte TJ
    Respirology; 2016 Nov; 21(8):1438-1444. PubMed ID: 27427515
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prognostic impact of HNF4α expression in interstitial lung disease.
    Sawazumi T; Baba T; Iwasawa T; Arai H; Matsumura M; Takemura T; Sugiyama M; Sekiya M; Saigusa Y; Ogura T; Inayama Y; Ohashi K; Okudela K
    Pathol Int; 2022 Jan; 72(1):25-34. PubMed ID: 34643024
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Update on the diagnosis and classification of ILD.
    Ryerson CJ; Collard HR
    Curr Opin Pulm Med; 2013 Sep; 19(5):453-9. PubMed ID: 23872860
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Interstitial lung diseases : Classification, differential diagnosis and treatment approaches in a heterogeneous group of chronic lung disorders].
    Lederer C; Buschulte K; Hellmich B; Heußel CP; Kriegsmann M; Polke M; Kreuter M
    Inn Med (Heidelb); 2023 Mar; 64(3):247-259. PubMed ID: 36786822
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Idiopathic interstitial pneumonias: progress in classification, diagnosis, pathogenesis and management.
    King TE
    Trans Am Clin Climatol Assoc; 2004; 115():43-76; discussion 76-8. PubMed ID: 17060957
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [The evaluation of 92 interstitial lung disease patients].
    Sengül B; Uzun O; Findik S; Atici AG; Erkan L
    Tuberk Toraks; 2009; 57(3):314-26. PubMed ID: 19787471
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of disease progression and mortality of connective tissue disease-related interstitial lung disease and idiopathic interstitial pneumonia.
    Kocheril SV; Appleton BE; Somers EC; Kazerooni EA; Flaherty KR; Martinez FJ; Gross BH; Crofford LJ
    Arthritis Rheum; 2005 Aug; 53(4):549-57. PubMed ID: 16082627
    [TBL] [Abstract][Full Text] [Related]  

  • 57. What every radiologist should know about idiopathic interstitial pneumonias.
    Mueller-Mang C; Grosse C; Schmid K; Stiebellehner L; Bankier AA
    Radiographics; 2007; 27(3):595-615. PubMed ID: 17495281
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Increased pulmonary neurotrophin protein expression in idiopathic interstitial pneumonias.
    Ricci A; Graziano P; Bronzetti E; Saltini C; Sciacchitano S; Cherubini E; Renzoni E; Du Bois RM; Grutters JC; Mariotta S
    Sarcoidosis Vasc Diffuse Lung Dis; 2007 Mar; 24(1):13-23. PubMed ID: 18069415
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical characteristics of patients with familial idiopathic pulmonary fibrosis (f-IPF).
    Krauss E; Gehrken G; Drakopanagiotakis F; Tello S; Dartsch RC; Maurer O; Windhorst A; von der Beck D; Griese M; Seeger W; Guenther A
    BMC Pulm Med; 2019 Jul; 19(1):130. PubMed ID: 31319833
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fibrosing interstitial pneumonia predicts survival in patients with rheumatoid arthritis-associated interstitial lung disease (RA-ILD).
    Solomon JJ; Ryu JH; Tazelaar HD; Myers JL; Tuder R; Cool CD; Curran-Everett D; Fischer A; Swigris JJ; Brown KK
    Respir Med; 2013 Aug; 107(8):1247-52. PubMed ID: 23791462
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.